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Cytokine expression was also ana-
lyzed in skin-draining lymph nodes (LN;
Figure 2l). Upon MC903 treatment, the
induction of Th2 cytokines (IL4, IL13,
IL10, IL6, and IL31) in WT LNs was not
observed in TSLPep/ LNs, indicating
that the MC903-triggered Th2 response
is abolished in TSLPep/ mice. No
change was seen for IFNg transcript
levels in WT or TSLPep/ LNs, from
either MC903- or ethanol-treated mice,
suggesting that MC903 application does
not involve a Th1 response in LNs.
In conclusion, we demonstrate un-
equivocally here that TSLP produced by
keratinocytes is absolutely required in
pathogenesis of AD triggered by topical
application of the vitamin D3 analogue
MC903. We also show that in this AD
model, induction of IL4, IL13, IL31, and
eotaxin-2 is fully TSLP dependent,
whereas that of IL6, IL10, and mono-
cyte chemotactic protein-2 is only
partially TSLP dependent, and that of
IFNg is TSLP independent. Finally, our
floxed TSLP mice will be helpful for
selective ablation of TSLP in other cell
types (Soumelis and Liu, 2004; Ziegler
and Liu, 2006; Holgate, 2007; Sokol
et al., 2008), and therefore to further
elucidate the physiological and patho-
logical function of this cytokine.
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TO THE EDITOR
Individuals with xeroderma pigmento-
sum syndrome (XP) present an extre-
mely high sensitivity to sunlight, with
increased incidence of skin cancer
(especially in sun-exposed areas), when
compared to the normal population.
Some XP patients can also display
developmental complications and early
aging features.
A genetic defect in the nucleotide
excision repair pathway (NER) was
described as the molecular cause of
XP syndrome (Cleaver, 1968), and
somatic cell fusion accompanied by
Abbreviations: FHN, normal human fibroblast; NER, nucleotide excision repair; UDS, unscheduled DNA
synthesis; UV, ultraviolet; XP, xeroderma pigmentosum
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functional complementation using un-
scheduled DNA synthesis (UDS) assays
led to the identification of seven com-
plementation groups, which corre-
spond to some of the genes involved
in NER (designated XPA to XPG) (Costa
et al., 2003; Lehmann, 2003). Among
these genes, mutations in XPA and XPC
are the most frequent and are respon-
sible for approximately half of all XP
cases in the world (Zeng et al., 1997).
All described XP mutations can be
found in the XP mutations database
(http://xpmutations.org).
This work describes mutations in
fibroblasts obtained from three children
with clinical diagnosis of XP, from two
nonrelated families. All three patients
were born from consanguineous mar-
riages and manifested sunburning on
minimal sun exposure, photophobia,
and corneal and eye lid deformities.
None of them presented neurological
abnormalities. The XP02SP patient is 12
years old and displayed several cuta-
neous tumors in sun-exposed areas,
beginning at age 7 (basal-cell carcino-
mas, squamous-cell carcinoma, malig-
nant fibrohistiocytoma, and atypical
in situ melanocyte proliferation). The
XP03SP patient is also a 12-year old,
and developed actinic keratosis and
basal-cell carcinomas at the age of 8
years. Patient XP04SP, brother of patient
XP03SP, died at age 13 after complica-
tions of an invasive and extremely
agressive squamous-cell carcinoma that
led to partial destruction of his face. This
patient also had a T-cell lymphoma at
the age of 3, curiously not commonly
observed in XP patients, which re-
sponded to chemotherapy, although an
acceleration of the progression of skin
lesions was observed during treatment.
To determine XP patients’ comple-
mentation group, fibroblasts from skin
biopsies of patients were infected with
recombinant adenovirus carrying XPA
(AdyXPA) or XPC (AdXPC; Muotri et al.,
2002) functional cDNA and, later, gene
complementation was analyzed by
UDS. For noninfected cells, UV-irra-
diated NER-proficient fibroblasts pre-
sented a high number of nuclear grains,
whereas cells from patients exhibited
reduced UDS levels, confirming their
XP diagnoses. Cells infected with
AdyXPA (Figure 1a) did not present
any increase in grain number. In con-
trast, after the XP fibroblasts were
infected with AdXPC, the levels of
UDS increased to values comparable to
those of NER-proficient cells (Figure 1b).
To further confirm the complemen-
tation of DNA repair deficiency by
AdXPC infection, XP and proficient
DNA repair cells were irradiated with
UV light, and cell survival was mea-
sured 7 days later (Figure 1c–f). At the
doses employed, UV irradiation was
not able to generate a significant
reduction of survival rates in DNA
repair proficient cells (normal human
fibroblast, FHN), regardless of previous
infection with AdXPC. On the other
hand, XP02SP, XP03SP, and XP04SP
cells became more resistant to
irradiation effects when previously
infected with AdXPC. No changes in
cell-survival levels were observed in
cells infected with AdyXPA (data not
shown).
Total RNA and genomic DNA from
cell lineages of FHN, XP02SP, XP03SP,
and XP04SP were extracted to identify
molecular mutations in the XPC gene.
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Figure 1. Identification of XP complementation group. Evaluation of NER activity by UDS for the cells
from the different patients, after infection with AdyXPA (a) or AdXPC (b). Only NER-proficient cells, HCB1
and cells XP02SP, XP03SP and XP04SP infected with AdXPC presented grain number incidence after
irradiation. The activity of NER is estimated by number of grains in this essay. UV dose is indicated.
Survival curves of proficient NER fibroblast FHN (c), XP02SP (d), XP03SP (e) and XP04SP (f) XTT was
applied to the medium 7 days after UV irradiation in order to determine cells’ metabolic activity. Closed
symbols with continuous lines correspond to cells infected with AdXPC 24 hours before irradiation; open
symbols with discontinuous lines correspond to non infected cells. All the methodology used in this work
is presented in the supplementary materials and methods.
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Three amplification products resulted in
strong and well-defined bands. The
amplification of regions c.1_895 (from
exon 1 to exon 6) and c.732_1549 (end
of exons 5.2 to the first half of the exon
8) result in cDNA fragments with the
expected sizes for all cells. However,
the product of cDNA amplification for
region c.1480_2249 (including the sec-
ond half of exon 8 to part of exon 11),
resulted in bands of the expected sizes
(791 bp) for control cells, but different
fragments were also observed for the
cells from patients (Figure 2a).
The cDNA and genomic DNA from
cells were sequenced, and the genetic
alterations identified in the XPC se-
quence are described in Table 1. Sche-
matic representation of the mutation
observed in one of the XP cells is shown
in Figure 2b. Many of the variations
correspond to polymorphisms that have
already been reported (Table 1).
DNA sequencing for XP02SP cells
revealed to our knowledge a previously
unreported mutation c.1969G4T
(p.Glu657X) at exon 9 for the longer
cDNA fragment and for genomic DNA
(Figure 2b and c) and a deletion of exon
9 (c.1874_2034) present only at the
smaller cDNA amplification fragment
(2c). This deletion was not detected in
genomic DNA and probably resulted
from an mRNA splicing error. The
deletion and the mutation potentially
generate a truncated protein, with
incomplete HR23B and DNA interaction
domains and the TFIIH interaction
site completely absent (Uchida et al.,
2002).
Genomic sequencing revealed
a c.1643-1644delTG present at exon
8 in XP03SP cells. This last mutation
was confirmed by cDNA sequencing of
XP04SP cells (Figure 2c). Another
mutation was also observed in the
cDNA from XP04SP cells: a deletion
of 245 bp of the second half of exon 8
(c.1627_1872del). The two mutations
observed for the cDNA on XP03SP and
XP04SP potentially generate a frame-
shift and truncated XPC protein that
affects the sites of HR23B, TFIIH inter-
actions, and DNA binding. The
c.1643_1644delTG as well as the
cDNA deletion (c.1627_1872del) were
previously described for XP26PV cells
obtained from Italian patients and un-
related kindreds (Chavanne et al.,
2000), although the same deletion
(c.1627_1872 del) was also described
as a result of alternative spliced XPC
mRNA, from a cryptic splice site, not XP
related (Gozukara et al., 2001). The
deletion of two bases (c.1643_1644
delTG) was proposed to originate from
DNA polymerase slippage at the DNA
segment containing a three repeated TG,
and configures a hotspot mutation pre-
sent at the XPC gene (Chavanne et al.,
2000; Khan et al., 2006).
In summary, this study presents the
use of recombinant adenovirus carrying
XP genes as an efficient tool for diagnosis
of XP patients’ complementation groups
and confirms the molecular character-
ization of two mutations of the XPC gene
obtained from Brazilian XP patients,
adding to our knowledge a previously
unreported mutation causing this syn-
drome. Besides XPA and XPC genes,
recombinant adenovirus carrying XPD
and XPV genes are also available for
complementation analysis (Armelini
et al., 2005; Lima-Bessa et al., 2006).
We propose the use of these recombi-
nant viruses as an alternative to the other
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Figure 2. Molecular characterization of XPC mutations. (a)RT-PCR analysis with primers pair of the region c.1480_2249 of XPC from cells FHN (lane 1),
XP02SP (lane 2), XP03SP (lane 3), XP04SP (lane 4) and water (lane 5) presenting bands with unexpected sizes in XP cells. (b) Alignment of genomic DNA, XPC
exon 9, indicating a new mutation in c.1969G4T in XP02SP cells. Phrap qualityX20. (c) Representation of XPC sequenced genes and mutations characterized
from genomic DNA and cDNA from XP02SP, XP03SP and XP04SP cells. The exons correspond to rectangles and black regions correspond to sequenced areas
with quality PhrapX20. Dotted line represents regions absent in cDNA sequences. XPC pairs of primers used for the RT-PCR as well as the expected amplicons
are shown in Figure S1 and genomic and cDNA primers are presented in Table S1.
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methods used for XP complementation
diagnostics, such as somatic cell fusion
(Cleaver et al., 1975) and gene reporter
after plasmid transfection assays (Carreau
et al., 1995; Khan et al., 1998).
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Potential Stimulators of Normal Hair Regrowth by
‘‘Dystrophic Catagen’’ Promotion?
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TO THE EDITOR
Chemotherapy-induced hair follicle
(HF) dystrophy and alopecia are major
unresolved problems in clinical onco-
logy (Wang et al., 2006; Bodo´ et al.,
2007; Lemieux et al., 2007). Although
the study of cyclophosphamide-
induced alopecia in mice has provided
important pointers to potentially
useful agents that might deserve clinical
testing and has allowed us to dissect
some of the basic pathobiological me-
chanisms (Paus et al., 1994, 1996; Schilli
et al., 1998; Botchkarev et al., 2000;
Ohnemus et al., 2004; Sredni et al.,
2004; Hendrix et al., 2005), the—as yet
unmet—challenge is to develop a con-
vincing preclinical assay system that
allows one to predict how chemother-
apy-treated human scalp HFs respond to
the various candidate alopecia protec-
tants that have surfaced from rodent
studies.
Recently, we established a human
in vitro model for studying chemother-
apy-induced HF dystrophy (Bodo´ et al.,
2007), which reliably re-produces the
HF damage seen in vivo. In this assay,
cyclophosphamide, a classical cyto-
static agent that frequently causes
chemotherapy-induced alopecia in
clinical medicine (Braun-Falco, 1961)
is replaced by one of its active toxic
metabolites normally generated in vivo,
4-hydroperoxycyclophosphamide (4-
HC). Using this human model we could
show that 4-HC profoundly inhibits hair
shaft elongation, matrix keratinocyte
proliferation, induces massive apopto-
sis of matrix keratinocytes and melanin
clumping (Bodo´ et al., 2007).
Chemotherapy-induced HF damage
follows two distinct pathways: dys-
trophic anagen and dystrophic catagen
(Paus et al., 1994; Hendrix et al., 2005).
During the dystrophic anagen pathway,
the hair shaft is shed, and the follicle
undergoes an incomplete ‘‘primary
recovery’’ during an (paradoxically
prolonged!) anagen phase. This is fol-
lowed by a retarded ‘‘secondary recov-
ery’’ during which a normal hair shaft is
generated in the subsequent anagen
phase. By contrast, HFs that undergo
the dystrophic catagen (DC) pathway
(for example, in response to a higher
dose of chemotherapy) immediately
enter into a dystrophic catagen stage,
followed by an abnormally shortened
telogen phase, and thus rapidly enter
into secondary recovery by premature
induction of a new anagen phase.
Therefore, even though it is clinically
associated with the most dramatic
effluvium/alopecia, the DC pathway
leads to the fastest, complete HF
recovery (Paus et al., 1994; Hendrix
et al., 2005).
In mice, in vivo, topical application
of steroid hormones (dexamethasone,
calcitriols, or 17-b-estradiol (E2)) before
and after systemic cyclophosphamide
administration potently promotes the
DC pathway. Thus, these steroid hor-
mones greatly enhance the initial
alopecia, but maximally accelerate the
regrowth of normally pigmented hair
shafts as HF ‘‘secondary recovery’’ is
optimally enhanced (Paus et al., 1994;
Schilli et al., 1998; Ohnemus et al.,
2004).
Therefore, we were interested in
studying how E2 or a combination of
E2 with glucocorticosteroids would
affect 4-HC-induced human scalp HF
damage in our new human in vitro
model (Bodo´ et al., 2007), and whether
there are any indications where these
steroid hormones, alone or in combina-
tion, promote the DC pathway. We
purposely selected E2 and a combina-
tion with prednisolone (P) for further
study, as the topical application of both
has a long tradition of clinical applica-
tion in central European dermatology
for hair loss management (Abadjieva,
2000; Wu¨stner and Orfanos, 1974).
Due to the extremely limited number
of available human scalp HFs, we
opted for testing of one E2 and P
concentration, and selected 107 M
after selected (Kanda and Watanabe,
2004).
Anagen VI HFs were isolated from
normal human scalp skin from healthy
female patients undergoing routine
face-lift surgery (obtained after ethics
committee approval and written con-
sent from patient, adhering to Helsinki
guidelines) as described (Philpott et al.,
1990). We received HFs (10–18 HFs per
Abbreviations: 4-HC, 4-hydroperoxicyclophosphamide; DC, dystrophic catagen pathway; E2, 17-b
estradiol; HF, hair follicle; P, prednisolone
506 Journal of Investigative Dermatology (2009), Volume 129
E Bodo´ et al.
17-b Estradiol Promotes Dystrophic Catagen
